Moving Beyond JAK Inhibitors in Myeloproliferative Neoplasms

1 Visningar
administrator
administrator
07/29/23

Naveen Pemmaraju, MD, discusses the need to move beyond JAK inhibition when treating patients with myeloproliferative neoplasms.

  • Kategori

Visa mer

0 Kommentarer Sortera efter

Inga kommentarer hittades

Facebook-kommentarer

Strax